Safety and efficacy of MIM D3 ophthalmic solutions in a randomized placebo controlled Phase 2 clinical trial in patients with dry eye
Authors:
Open Access
- 1 June 2013
- journal article
- Published by Taylor & Francis in Clinical Ophthalmology
- Vol. 7, 1275-85
Abstract
Peer reviewed article authored by (Meerovitch K, Torkildsen G, Lonsdale J, Goldfarb H, Lama T, Cumberlidge G, Ousler GW III). Read article or submit your manuscript for publishing.Keywords
This publication has 32 references indexed in Scilit:
- The Corneal Pain System. Part I: The Missing Piece of the Dry Eye PuzzleThe Ocular Surface, 2012
- Blink Rate, Blink Amplitude, and Tear Film Integrity during Dynamic Visual Display Terminal TasksCurrent Eye Research, 2010
- Research in Dry Eye: Report of the Research Subcommittee of the International Dry Eye WorkShop (2007)The Ocular Surface, 2007
- The Definition and Classification of Dry Eye Disease: Report of the Definition and Classification Subcommittee of the International Dry Eye Workshop (2007)The Ocular Surface, 2007
- Impact of evaporation on aqueous tear loss.2006
- Topical Combination of NGF and DHA Increases Rabbit Corneal Nerve Regeneration after Photorefractive KeratectomyInvestigative Ophthalmology & Visual Science, 2005
- The Effect of Nerve Growth Factor on Corneal Sensitivity After LaserIn Situ KeratomileusisArchives of Ophthalmology (1950), 2004
- The Relationship between Habitual Patient-Reported Symptoms and Clinical Signs among Patients with Dry Eye of Varying SeverityInvestigative Ophthalmology & Visual Science, 2003
- Nerve growth factor promotes corneal healing: structural, biochemical, and molecular analyses of rat and human corneas.2000
- Growth factors modulate clonal growth and differentiation of cultured rabbit limbal and corneal epithelium.1993